Mateusz Wydro
Vice President of CMC and Development
Mateusz serves as Vice President of Chemistry, Manufacturing and Controls (CMC) and Development at T-Therapeutics. He brings deep expertise in the development and manufacturing of biological therapeutics, with a strong track record of ensuring that molecules meet the high standards of developability and manufacturability, building outsourced supply chains and supporting global regulatory submissions.
Prior to joining T-Therapeutics, Mateusz held senior CMC leadership roles at invoX Pharma and F-star Therapeutics, where he developed and implemented robust and scalable manufacturing strategies and contributed to the advancement of several bispecific antibody therapies into clinical development.
Mateusz holds a PhD from the Faculty of Medical Sciences at Newcastle University and an MSc in Biotechnology from Adam Mickiewicz University in Poland.
